Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maraveyas

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|November 10, 1998
Improving tumour targeting and decreasing normal tissue uptake by optimizing the stoichiometry of a two-step biotinylated-antibody/streptavidin-based targeting strategy: studies in a nude mouse xenograft modelA Maraveyas, G Rowlinson-Busza, S Murray, et al.
Thrombosis and Haemostasis|April 24, 2015
Accumulation of tissue factor in endothelial cells induces cell apoptosis, mediated through p38 and p53 activationA M ElKeeb, M E W Collier, A Maraveyas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1995
Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapyC Kosmas, A Maraveyas, C S Gooden, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 21, 2011
Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?M Hingorani, T Crosby, A Maraveyas, et al.
Thrombosis and Haemostasis|August 16, 2013
Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activityM E W Collier, P-M Mah, Y Xiao, et al.
Cancer Research|March 1, 1995
Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinomaA Maraveyas, N Stafford, G Rowlinson-Busza, et al.
British Journal of Cancer|February 17, 2005
Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I studyA Maraveyas, J Sgouros, S Upadhyay, et al.
International Journal of Laboratory Hematology|February 22, 2012
Tissue factor expression determines tumour cell coagulation kineticsJ Welsh, J D Smith, K R Yates, et al.
Cancer Research|March 1, 1995
Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissuesA Maraveyas, M Myers, N Stafford, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1995
Direct technetium-99m labeling of three anticancer monoclonal antibodies: stability, pharmacokinetics and imagingC S Gooden, D E Snook, A Maraveyas, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|November 10, 1998
Improving tumour targeting and decreasing normal tissue uptake by optimizing the stoichiometry of a two-step biotinylated-antibody/streptavidin-based targeting strategy: studies in a nude mouse xenograft modelA Maraveyas, G Rowlinson-Busza, S Murray, et al.
Thrombosis and Haemostasis|April 24, 2015
Accumulation of tissue factor in endothelial cells induces cell apoptosis, mediated through p38 and p53 activationA M ElKeeb, M E W Collier, A Maraveyas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1995
Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapyC Kosmas, A Maraveyas, C S Gooden, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 21, 2011
Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?M Hingorani, T Crosby, A Maraveyas, et al.
Thrombosis and Haemostasis|August 16, 2013
Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activityM E W Collier, P-M Mah, Y Xiao, et al.
Cancer Research|March 1, 1995
Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinomaA Maraveyas, N Stafford, G Rowlinson-Busza, et al.
British Journal of Cancer|February 17, 2005
Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I studyA Maraveyas, J Sgouros, S Upadhyay, et al.
International Journal of Laboratory Hematology|February 22, 2012
Tissue factor expression determines tumour cell coagulation kineticsJ Welsh, J D Smith, K R Yates, et al.
Cancer Research|March 1, 1995
Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissuesA Maraveyas, M Myers, N Stafford, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1995
Direct technetium-99m labeling of three anticancer monoclonal antibodies: stability, pharmacokinetics and imagingC S Gooden, D E Snook, A Maraveyas, et al.
Pageof 4